Tri Locum Partners LP Aldeyra Therapeutics, Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $519,506 - $868,766	73,067 New	73,067 $613,000
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $3.52 Million - $7.02 Million	-1,447,445 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.25 - $5.17 $4.7 Million - $7.48 Million	1,447,445 New	1,447,445 $6.43 Million
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $6.5 Million - $9.25 Million	-818,025 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $8.54 Million - $12.1 Million	818,025 New	818,025 $9.27 Million

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $278M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.